ALDA Pharmaceuticals Corp.
TSX VENTURE : APH

ALDA Pharmaceuticals Corp.

December 05, 2006 10:26 ET

ALDA Retains Group 270 to Pursue Retail Sales of T36'R' Personal Disinfectant

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Dec. 5, 2006) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) ("ALDA") announces that it has retained Group 270 Sales & Marketing Inc. ("Group 270") to introduce ALDA's T36® Personal Disinfectant into major regional and national pharmacy chains across Canada. President and CEO of ALDA, Dr Terrance Owen states, "T36® Personal Disinfectant is a unique product that can be sprayed on any surface to provide consumers with safe and effective protection from infectious organisms. For example, it can be used on toilets, cutting boards, cell phones, keyboards, door handles and even on your hands while traveling or handling money. There are virtually no limits to its uses and Group 270 will be taking our product to significant new markets that we do not currently serve."

About Group 270

Group 270 is a full service sales and marketing agency specializing in bringing innovative non-prescription drugs and personal care products to Canadian consumers. By combining its base of national and regional pharmacy customers, such as London Drugs and Shoppers Drug Mart, with product development expertise, Group 270 is able to offer effective sales solutions to maximize brand growth.

About ALDA

ALDA Pharmaceuticals Corp.'s T36® Personal Disinfectant is a wide spectrum, non-toxic, non-corrosive, biodegradable infection control product designed for personal use. It is acknowledged to be effective against all fungi, bacteria and viruses including Avian Flu, SARS, Norwalk Virus, HIV, Legionella and Hepatitis because of its ability to kill polio and TB.

Terrance G. Owen, Ph.D., MBA, President, CEO and Director

ALDA Pharmaceuticals Corp.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information